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ABSTRACT
Non-coding RNAs (ncRNAs) are versatile regulators
in cellular networks. While most trans-acting
ncRNAs possess well-defined mechanisms that
can regulate transcription or translation, they gen-
erally lack the ability to directly sense cellular
signals. In this work, we describe a set of design
principles for fusing ncRNAs to RNA aptamers to
engineer allosteric RNA fusion molecules that
modulate the activity of ncRNAs in a ligand-
inducible way in Escherichia coli. We apply these
principles to ncRNA regulators that can regulate
translation (IS10 ncRNA) and transcription (pT181
ncRNA), and demonstrate that our design strategy
exhibits high modularity between the aptamer
ligand-sensing motif and the ncRNA target-
recognition motif, which allows us to reconfigure
these two motifs to engineer orthogonally acting
fusion molecules that respond to different ligands
and regulate different targets in the same cell.
Finally, we show that the same ncRNA fused
with different sensing domains results in a
sensory-level NOR gate that integrates multiple
input signals to perform genetic logic. These
ligand-sensing ncRNA regulators provide useful
tools to modulate the activity of structurally
related families of ncRNAs, and building upon the
growing body of RNA synthetic biology, our ability
to design aptamer–ncRNA fusion molecules offers
new ways to engineer ligand-sensing regulatory
circuits.
INTRODUCTION
Small, non-coding RNAs (ncRNAs) are key regulators
and defenders of the genome in all organisms (1). In pro-
karyotes, these ncRNAs are being discovered at an
accelerating rate, and have been shown to coordinate
with proteins to form complex networks that govern im-
portant cellular responses to stress and other environmen-
tal cues (2). This ubiquity suggests their utility in the
control and tuning of cellular regulatory networks. In syn-
thetic biology, trans-acting ncRNAs have been shown to
have advantages in circuit engineering (3), and orthogon-
ally acting ncRNA regulators that work independently in
the same cell have been used to engineer higher-order
regulatory functions (4–8).
A large number of trans-acting ncRNA molecules,
however, function solely as wires of gene circuits, linking
the activity of one genetic element to another (9). They
therefore possess a well-defined and often highly tunable
mechanism to regulate transcription or translation of
target genes, but lack the ability to directly sense cellular
signals. To expand the versatility of these ncRNAs, we
propose to engineer ligand-inducible switching capability
into trans-acting ncRNA molecules by fusing them with
molecule-sensing RNA aptamers. We expect the strategy
of adding ligand-sensing ability to ncRNA regulators
will add an extra sensory layer to the increasingly
sophisticated designs of circuits that utilize ncRNA
regulations.
Bacterial trans-acting ncRNAs usually possess highly
structured conformations (9). Examples of allosteric inter-
actions between structured RNA elements and aptamers
exist in natural cis-acting riboswitches (10), which usually
consist of two structural motifs fused together—an
aptamer, and an expression platform that converts
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ligand binding at the aptamer into a structural rearrange-
ment that can block or allow the formation of functional
hairpins (11). Our aptamer–ncRNA fusions are designed
to recapitulate this ligand-dependent structural rearrange-
ment, and we hypothesize that disruptions on ncRNA
structure could be actuated through the designed fusion
of RNA aptamers that would interfere with the ncRNA
structure until bound to its cognate ligand (Figure 1).
Two primary types of natural ncRNA regulators acting
on the 50-untranslated regions (UTRs) are engineered for
designing custom regulations (Supplementary Figure S1).
The first are regulators of transcriptional elongation, and
recent studies have shown a family of orthogonal ncRNA
regulators derived from the pT181 antisense RNA could
attenuate transcription independently (4). The second are
regulators of translational initiation, and recent work have
shown a family of orthogonal ncRNA regulators derived
from the IS10 antisense RNA could inhibit translation
with high specificity (12). Both pT181-derived and
IS10-derived ncRNA systems have been shown as versatile
regulatory platforms for constructing synthetic gene
circuits in vivo. In this work, we describe design principles
that allow fusion of these two types of trans-acting
ncRNAs to RNA aptamers for allosteric modulation of
ncRNA functions by ligands in Escherichia coli. We begin
by fusing the IS10 ncRNA to the well-studied theophylline
aptamer using a designed ‘pseudoknot’ interaction to
create a theophylline-responsive translational regulator.
We show that a similar design leads to a theophylline-
responsive pT181-derived transcriptional regulator. We
then demonstrate that an alternative design using ‘strand
exchange’ exhibits similar allosteric switching functions.
Using this design, we can modularly fuse different
aptamers sensing either theophylline or the MS2 coat
protein to the pT181 ncRNA. We show that this design
strategy is robust to modifications of the ncRNA target
recognition motif, which have been engineered to create
orthogonal ncRNA-attenuator pairs. Since these orthog-
onal pairs serve as a toolbox for engineering RNA-based
gene circuits, the sensing capability adds an extra ‘sensory’
layer of these RNA-based circuits. We finish by showing
that this is indeed the case by creating a two-input NOR
gate using two designed ncRNA fusions that integrate a
small molecule and a protein signal to perform genetic
logic.
MATERIALS AND METHODS
Plasmid construction
Plasmids used in this study are described in
Supplementary Table S1. Their sequences are listed in
Supplementary Table S2. The sequences of functional
aptamer–ncRNA fusions are summarized in
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Figure 1. The proposed riboswitch-like design for the aptamer–ncRNA fusion. (A) A riboswitch usually consists of an aptamer (black color) coupled
to a structured expression platform (red color). The structural interaction between the aptamer and the expression platform could inactivate (left) or
activate (right) the expression platform depending on the presence of ligand. (B) We propose to fuse the aptamer and the ncRNA (blue color) in a
similar architecture. The designed structural interaction between the aptamer and the ncRNA mutation regions (black color) would inactivate
ncRNA without the ligand (left). Ligand binding could eliminate such structural interactions and activate the ncRNA (right).
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Supplementary Table S3. Supplementary Tables S4–S7 list
the sequences of all fusion designs used for screening.
Supplementary Figure S1C outlines the plasmids that
harbor IS10 and pT181 systems used in the study. All
restriction enzymes were purchased from New England
Biolabs. Oligonucleotides were ordered from Integrated
DNA Technologies. All chemicals were purchased from
Sigma–Aldrich unless otherwise indicated. Plasmids were
sequencing verified by QuintaraBio. The IS10 reporter
plasmid with the pSC101 replication origin and a chlor-
amphenicol resistance marker, contained 40-nt IS10 target
sequences with an embedded Shine–Dalgarno sequence
and an AUG start codon that were translationally fused
to the second amino acid of the reporter gene sfGFP (13).
The pT181 reporter plasmid with the p15A replication
origin and a chloramphenicol resistance marker, con-
tained the 287-nt pT181 target sequences that were tran-
scriptionally fused to the downstream reporter gene
sfGFP. Different aptamer–ncRNA fusion mutants were
cloned onto a vector with the ColE1 replication origin
and an ampicillin resistance marker. Pairs of ultramers
(i.e. oligonucleotides >60 nt) containing 30-nt complemen-
tary regions were synthesized and PCR amplified to
generate aptamer–ncRNA mutant cassettes, which were
then digested and ligated to the vector. The E. coli
promoter J23119 (http://partsregistry.org/Part:BBa_
J23119), modified to include a SpeI site right before the
start of transcription, was used for expression of the
reporter gene and aptamer–ncRNA fusions. The MS2
aptamer–ncRNA fusion plasmids also contained cassettes
expressing either MS2 coat protein or MS2–RFP fusion
protein under the inducible PLlacO-1 promoter (14). This
was done by cloning the whole cassettes from the plasmid
pCT119 for the MS2 coat protein (a gift from Dr D.
Peabody) or from the plasmid K133 for the MS2–RFP
fusion protein (a gift from Dr I. Golding) onto the MS2
aptamer–ncRNA fusion plasmids.
Strains, growth media and in vivo fluorescence assays
using plate reader
All in vivo fluorescence experiments were performed in
E. coli Top10 strain (Invitrogen). Plasmid combinations
were transformed into competent cells, plated on Difco
LB+Agar plates containing 100 mg/ml carbenicillin and
34 mg/ml chloramphenicol, and incubated overnight at
37C. In all experiments, three colonies were picked into
300 ml of Difco LB containing 100 mg/ml carbenicillin and
34 mg/ml chloramphenicol in a 2-ml, 96-well block (Costar
3960) and grown overnight in a Labnet Vortemp 56 bench
top shaker at 37C with 1000 rpm shaking speed.
Ten microliters of this overnight culture was then added
to 240 ml (1:25 dilution) of supplemented M9 Minimal
Media (pH 7.4) with 0.2% casamino acids (Fisher
Scientific), selective antibiotics, and proper concentrations
of theophylline or IPTG (Fisher Scientific), and incubated
overnight at 37C and 1000 rpm. A second fresh 96-well
plate containing 240ml of the same supplemented M9
minimal media with same concentrations of theophylline
or IPTG was inoculated by overnight minimal media
culture with 1:25 dilution factor. Once the cells grew to
mid-log phase, fluorescence was assayed. Cell cultures
with volume of 100 ml mixed with 100 ml of
phosphate-buffered saline (PBS) were transferred to
96-well plates, and fluorescence [excitation at 485 nm,
emission at 510 nm for sfGFP; excitation at 587 nm,
emission at 610 nm for RFP (15)] and ODs (optical
densities, measured at 600 nm, were similar among experi-
ments and fell in the linear range of our instruments) were
then measured using a fluorescence plate reader (Tecan
Safire2). The ratio of fluorescence to optical density
(RFU/OD) was calculated and the background RFU/
OD corresponding to Top10 cells without fluorescent
proteins was subtracted.
In vivo fluorescence using flow cytometry
Cell culture with volume of 5 ml mixed with 250 ml PBS
containing 2mg/ml kanamycin were transferred to
96-well plates, and assayed using the flow cytometer
(Partec Cyflow Space) in the five parameters of time,
forward scatter (FSC), side scatter (SSC), GFP fluores-
cence (excitation at 500 nm, emission at 527 nm) and
RFP fluorescence (excitation at 590 nm, emission at
610 nm). Data for at least 50 000 cellular counts (triggered
by SSC) were collected for each sample. The mean auto-
fluorescence distribution of Top10 cells without fluor-
escent proteins was also measured. Counts were gated
by FSC and SSC, and the arithmetic mean of each distri-
bution is calculated using FCS Express Version 3.0 (De
Novo Software) with mean autofluorescence subtracted.
Single mutation assays
Single mutation plasmids were constructed by inverse
PCR amplification of the wild-type ncRNA plasmid
using two phosphorylated primers containing the desired
mutations, and self-ligated. These single mutations
plasmids were then transformed together with pT181
reporter plasmid into E. coli Tg1 cells (Zymo Research).
Three colonies were picked and inoculated as described
earlier. Fluorescence and OD were assayed using the
plate reader (Tecan Safire2).
In vitro RNA synthesis
A DNA template for transcription of the theo–P–IS10
ncRNA fusion molecules, inserted in the context of the
50 and 30 flanking selective 20-hydroxyl acylation
analyzed by primer extension (SHAPE) structure
cassette (16), was generated by PCR [1ml; containing
20mM Tris (pH 8.4), 50mM KCl, 2.5mM MgCl2,
200 mM each dNTP, 500 nM each forward and reverse
primer, 5 pM template and 0.025U/ml Taq polymerase;
denaturation at 94C, 45 s; annealing 55C, 30 s; and
elongation 72C, 1min; 34 cycles]. The PCR product
was recovered by ethanol precipitation and resuspended
in 150ml of TE [10mM Tris (pH 8.0), 1mM EDTA].
Transcription reactions (1.0ml, 37C, 12–14 h) contained
40mM Tris (pH 8.0), 20mM MgCl2, 10mM DTT, 2mM
spermidine, 0.01% (v/v) Triton X-100, 5mM each NTP,
50 ml of PCR-generated template, 0.12U/ml RNase
Inhibitor (Promega) and 0.1mg/ml of T7 RNA polymer-
ase. The RNA products was purified by denaturing
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polyacrylamide gel electrophoresis (8% polyacrylamide,
7 M urea, 29:1 acrylamide:bisacrylamide, 32 W, 2 h),
excised from the gel and recovered by passive elution
and ethanol precipitation. The purified RNA (3 nmol)
was resuspended in 200 ml TE.
SHAPE experiment
Structure-selective RNA modification with and without
theophylline was performed following the experimental
design of (17). For the without theophylline reaction,
10 pmol of RNA was suspended in 12 ml of nuclease free
water in a PCR tube. Using a thermocycler, the RNA was
heated to 95C for 2min, then placed on ice for 1min. Six
microliters of 3.3 folding buffer [333mM HEPES (pH
8.0), 333mM NaCl, 33mM MgCl2] was added, followed
by incubation at 37C in the thermocycler for 20min.
Nine microliters of this folded RNA solution was added
to either 1 ml 10 1M7 (65mM) (+reaction), or 1 ml neat
DMSO ( reaction), and further incubated at 37C.
Modified or control RNAs were then ethanol precipitated
following (18). For the with theophylline reaction, 10 pmol
of RNA was suspended in 10 ml of water in a PCR tube.
After identical heat denaturation steps, 2 ml of 9 theo-
phylline (4.5mM dissolved in water) was added, and 6 ml
of 3.3 folding buffer was added followed by identical
steps as above. The general procedure of primer extension
and data analysis followed (18), using 5 pmol of RNA for
ddA and ddT sequencing reactions.
Secondary structure prediction using SHAPE-Seq
reactivity constraints
SHAPE intensities were converted into a pseudo-free
energy change term in the RNAstructure program (19):
GSHAPE=m ln[SHAPE-Seq reactivity+1.0]+b
The intercept, b, is the free-energy bonus for formation
of a base pair with zero or low SHAPE reactivity, whereas
m, the slope, drives an increasing penalty for base pairing
as the SHAPE reactivity increases. These parameters
dictate the strength of the experimental contribution to
the energy function. The b and m parameters used were
0.5 and 3.4 kcal/mol, respectively.
RESULTS
Engineering a translational ncRNA to sense a small
molecule with a designed pseudoknot
The wild-type E. coli insertion sequence IS10 utilizes anti-
sense RNA-mediated translational inhibition to regulate
the expression of transposase (20). Following previous
work on engineering orthogonally acting variants of the
IS10 system (12), we used a single hairpin of the IS10
ncRNA. In-depth biochemical studies have shown that
the loop of IS10 ncRNA binds to the 50 most nucleotides
of its target transcript, which nucleates further hybridiza-
tion into the ribosome binding site of the target (21).
Furthermore, these studies have shown that single nucleo-
tide mutation of the loop nucleotides resulted in almost
complete loss of repression. We therefore sought to design
a pseudoknot interaction between the loop regions of the
aptamer and the ncRNA, such that the aptamer loop nu-
cleotides could interact with the ncRNA loop nucleotides
to disrupt its regulatory function (Figure 2A).
To start, we utilized the well-known theophylline
aptamer obtained by the Systematic Evolution of
Ligands by EXponential enrichment method (SELEX)
(22). The aptamer is a single RNA hairpin that binds theo-
phylline in an inner loop region with high affinity
(Kd=300 nM) (23,24). Previous studies have shown mu-
tations in the loop region were tolerated as long as the
loop structure was preserved (24). This allowed us to
mutate the loop of the theophylline aptamer to create a
hypothesized pseudoknot interaction between the aptamer
and the IS10 ncRNA. When fused to IS10 ncRNA, we
hypothesized that this pseudoknot would inhibit its regu-
latory activity in the absence of theophylline. In the
presence of theophylline, we expected that the aptamer
structure would be stabilized by the ligand, eliminating
the pseudoknot interaction between the loops and
restoring IS10 ncRNA function (Figure 2A).
We rationally designed seven different aptamer–IS10
ncRNA fusion mutants bearing different aptamer loop
mutations and tested them in vivo (Supplementary Text
S1 for design procedures). Each variant was transformed
into E. coli with a reporter plasmid containing the IS10
ncRNA UTR target controlling the downstream fluores-
cent protein sfGFP. Colonies were picked and grown with
and without theophylline, and fluorescence was measured
using the plate reader with two controls: a positive control
that lacked an aptamer–ncRNA sequence (high GFP),
and a negative control that expressed the IS10 ncRNA
not fused to any aptamer (low GFP). Four variants
(#3–#6) showed different levels of switching ability in
the presence of theophylline (Supplementary Figure S2).
From this set, mutant #6 was distinguished by both ob-
taining nearly the same maximal GFP expression as the
positive control and exhibiting the largest dynamic range
of repression between the two theophylline conditions. To
further characterize this mutant, called theo–P–IS10, we
assayed GFP expression for varying amounts of theophyl-
line using flow cytometry (Figure 2B). All fluorescence
histograms showed a single peak. A large dynamic range
(83.0%) was observed, which was close to the difference
between positive and negative controls (91.0%). This data
implied that, as designed, the fused aptamer interfered
with the function of ncRNA only in the absence of
theophylline, and that interaction of theophylline with
the aptamer released the ncRNA hairpin to regulate its
target.
To support this proposed mechanism, we carried out
SHAPE experiments on the theo–P–IS10 fusion
molecule to characterize its structure with and without
theophylline. The SHAPE experiment uses a structure-
dependent chemical probe, here 1-methyl-7-nitroisatoic
anhydride (1M7), to modify RNA molecules preferentially
at positions of high nucleotide flexibility (25). After modi-
fication, RNAs are converted to cDNAs by a reverse tran-
scriptase primer extension reaction, which is blocked by
adducts. cDNA products are then analyzed by capillary
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electrophoresis to infer the location of adduct formation
via cDNA length, and the intensity of adduct formation at
each nucleotide via the amount of cDNA of a given
length. These intensities are converted into reactivities,
with higher reactivity interpreted as positions of lower
or no RNA structure, and lower reactivity interpreted as
positions of strong RNA structure or nucleotide con-
straint (25).
We transcribed the theo–P–IS10 fusion molecule
in vitro, which was then folded with and without theophyl-
line, followed by SHAPE probing and analysis
(Supplementary Figure S3). Figure 2C plots the difference
in nucleotide reactivity between the two folding conditions
overlaid on a secondary structure model of the theo–P–
IS10 fusion. From this data, two reactivity changes can be
discerned. First, as expected, the ligand-binding pocket of
the aptamer shows a large drop in reactivity upon addition
of theophylline, indicating that these nucleotides become
constrained as they directly interact with theophylline.
Second, both aptamer and IS10 loops show consistent
but small increases in reactivity, suggesting that these nu-
cleotides probably become unconstrained in the presence
of theophylline. While the SHAPE analysis data is con-
sistent with our hypothesis and in vivo fluorescence assay
data that a designed pseudoknot interaction forms only in
the absence of theophylline to prevent the ncRNA loop
region from interacting with its target, we cannot rule out
the possibility that multiple aptamer-ncRNA fusions
dimerize with each other to affect their structures and
functions in a synergetic way.
Engineering a transcriptional ncRNA to sense a small
molecule with designed strand exchange
The Staphylococcus aureus plasmid pT181 uses antisense
RNA-mediated transcription attenuation to control copy
number (26). Similar to many trans-acting ncRNAs, the
pT181 ncRNA is highly structured (27). The pT181
ncRNA makes initial contact with the sense attenuator
through a loop–loop kissing interaction, and mutating
the loop nucleotides can decrease its attenuation
function (28). We therefore followed our pseudoknot
design strategy to fuse the theophylline aptamer to the
pT181 ncRNA.
Previous work has shown that mutations in only one
hairpin of pT181 ncRNA were sufficient to change its spe-
cificity of interaction with the sense attenuator (4), and we
confirmed here that this single hairpin was sufficient to
repress the target (Supplementary Figure S4A). The theo-
phylline aptamer was fused to this single hairpin, with the
aptamer loop nucleotides mutated to form pseudoknot
base-pairing with the pT181 ncRNA loop nucleotides
(Figure 3A). Similar to the above screening procedure of
IS10 fusion mutants, we tested eight different fusion
mutants with varying loop–loop pseudoknot interactions
in E. coli along with a reporter plasmid containing the
pT181 sense attenuator transcriptionally fused to sfGFP.
The mutant with the best performance (#4) under
screening (Supplementary Figure S5), called theo–P–
pT181, was further assayed with various concentrations
of theophylline using flow cytometry. Our results
showed that the pseudoknot design prevented the
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Figure 2. Designed theophylline aptamer–IS10 ncRNA fusions. (A) The theophylline aptamer sequences (blue) were fused to the 50 end of IS10
ncRNA (purple), and screening of seven designed pseudoknot mutants (Supplementary Figure S2) resulted in one functional fusion, theo–P–IS10
(P for pseudoknot). The proposed mechanism for allosteric switching of the fusion molecule is shown in the box. (B) Fluorescence assay of theo–P–
IS10 using flow cytometry. The induction curves were plotted from the average values of three biological replicates at each theophylline concen-
tration. The inset shows the cytometry histograms of three ligand concentrations (red—0.01 mM, green—100 mM, blue—2mM), with the two black
vertical lines showing the mean values of the positive and negative controls. The repression percentage between 2mM and 0.01mM theophylline is
83.0%, compared to 91.0% between the positive and negative controls. (C) SHAPE data of theo–P–IS10. The difference in nucleotide reactivity with
and without the ligand is overlaid on a hypothesized secondary structure model of theo–P–IS10 based on Refs (21) and (24). Colors represent the
changes of SHAPE reactivity upon addition of the ligand, with red colors showing positive changes (more flexible) and blues colors showing negative
changes (more stable). The blue box is the known ligand-binding pocket. The red boxes are designed pseudoknot interactions. Original SHAPE data
is available in Supplementary Figure S3A.
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ncRNA from acting in the absence of theophylline, and
allowed the ncRNA to repress the sense target when theo-
phylline was present (Figure 3A).
While the pseudoknot design strategy was effective, it
was not inherently modular as the aptamer loop sequences
must be adjusted to the ncRNA loop sequences. This was
particularly relevant to the pT181 ncRNA system, where
the loop region of the pT181 ncRNA has been exclusively
mutated to create orthogonally acting ncRNA-attenuator
systems (4). We hypothesized that we could engineer a
more modular aptamer–ncRNA fusion by designing an
interaction between the aptamer and the ncRNA stem
region, while leaving the ncRNA loop nucleotides for
modifying target specificity (Figure 3B). In this design,
named ‘strand exchange’, one strand on the ncRNA
stem is mutated to exhibit exchange between two
possible conformations of the aptamer–ncRNA fusion
molecule: one where the strand is base paired to the
aptamer causing the ncRNA to be non-functional
(ncRNA inactivated), and one where the strand is base
paired to the other strand of ncRNA to restore ncRNA
function (ncRNA activated). We hypothesized that theo-
phylline binding would cause strand exchange between the
conformations and bias the population of fusion mol-
ecules toward the activated conformation.
To verify that the mutation strategy would not disrupt
the function of pT181 ncRNA, we first carried out single
mutations to determine the regulatory importance of each
nucleotide (Supplementary Figure S4B and C). Each nu-
cleotide was mutated to its complementary nucleotide
(such as G to C, A to T, etc.), giving 58 mutant
ncRNAs each bearing a single mutation. The regulatory
activities of all 58 mutant ncRNAs were then assayed with
the pT181 reporter plasmid. By comparing with the
wild-type pT181 ncRNA, we found that nucleotides in
the lower stem can tolerate moderate modifications
without affecting the regulatory function.
We therefore mutated this lower stem region of the
pT181 ncRNA to base pair with the ligand-binding
pocket of the theophylline aptamer. We designed 15
aptamer–ncRNA fusion variants following the strand
exchange strategy, and measured their repression on the
pT181 sense target with and without theophylline
(Supplementary Figure S6). One mutant (#14) with the
highest dynamic range, called theo–SE–pT181, was
selected for assaying with varying amounts of theophylline
using flow cytometry. Figure 3B showed that repression
by the theo–SE–pT181 fusion molecule (83.4%) almost
covered the full dynamic range (86.6%) of the wild-type
ncRNA regulator. The data implied that the strand
exchange design was acting like an allosteric switch, with
theophylline triggering a change in the conformations to
allow the pT181 ncRNA to repress its target. To confirm
this switching behavior, we measured the temporal expres-
sion of the pT181 reporter gene under the control of theo–
SE–pT181, which showed that its expression was
BA
Figure 3. Alternative designs of theophylline-sensing pT181 ncRNA fusions. (A) Screening of eight designed pseudoknot mutants (Supplementary
Figure S5) results in theo–P–pT181, which displays strong theophylline-inducible repressive effects on its target. (B) An alternative design of
theophylline-sensing pT181 ncRNA fusions based on the strand-exchange strategy by mutating the lower bottom stem region of the ncRNAs.
The sequences of the best mutant screened from 15 mutants (Supplementary Figure S6) is shown as theo–SE–pT181 (SE for strand exchange). In vivo
fluorescence data from flow cytometry is shown on the bottom. The repression percentage between 3mM and 0.01 mM theophylline is 83.4%,
compared to 86.6% between positive and negative controls. The insets show the cytometry histograms corresponding to three ligand concentrations
in both (A) and (B).
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gradually repressed to the level of the negative control
(Supplementary Figure S7). The theophylline aptamer
used in the study does not bind caffeine that differs
from theophylline by a single methyl group (23). We
found that caffeine did not, as expected, repress gene ex-
pression in this system, implying that these aptamer–
ncRNA fusions retained a high level of ligand specificity
(Supplementary Figure S8).
To support our mechanistic hypothesis, we attempted to
perform SHAPE on the theo–SE–pT181 fusion. However,
the ncRNA hairpin prevented reverse transcriptase from
transcribing the full-length molecule (Supplementary
Figure S3B), thus precluding direct measurement of the
proposed structural transitions. As an alternative
approach, we computed the thermodynamic free energies
of substructures of four closely related aptamer–pT181
fusion variants using the RNA secondary structure predic-
tion algorithm Mfold (29) (Supplementary Text S2 and
Supplementary Figure S9). The data suggested that the
thermodynamic free energy of the two folds of the
aptamer–pT181 fusion were balanced in such a way that
allowed theophylline binding to bias the fold toward the
active conformation. The computation results also sug-
gested several principles in the design of switchable
aptamer–ncRNA fusions as was detailed in the
Discussion section.
The strand exchange design is modular with respect to
specificity-changing ncRNA mutations
Recent work has demonstrated that the pT181 system
served as a platform for engineering cellular gene
networks (4). In particular, multiple orthogonally acting
pT181 attenuators could be composed on the same tran-
script to logically control gene expression, and one sense
attenuator could control the transcription of another or-
thogonal pT181 ncRNA that propagated the signal in
RNA-mediated transcriptional cascades. Underlying
these two features was the ability to mutate the loop
region of the pT181 ncRNA hairpin to change its target
specificity, which led to the creation of ncRNA-attenuator
pairs that regulated multiple targets independently in the
same cell. Here we show that the strand exchange strategy
allows modularly fusing orthogonal pT181 ncRNAs with
RNA aptamers.
Since the specificity mutations located outside of the
lower stem region of the ncRNA that base-paired with
the aptamer, we used the same strand exchange design
to produce fusions with the mutant pT181 ncRNA,
called theo–SE–pT181MT (Figure 4A). We tested the or-
thogonality of theo–SE–pT181WT and theo–SE–
pT181MT against their cognate targets with and without
theophylline (Figure 4B). Measured GFP expression for
all four possible combinations of ncRNAs and their
targets under different theophylline conditions showed
that the theo–SE–pT181MT fusion responded to theo-
phylline in the same way as the theo–SE–pT181WT
fusion did (Figure 4C). Furthermore, both fusions were
orthogonal relative to each other’s target. These results
demonstrated the modularity of the strand exchange
design, and implied that these ligand-sensing fusion
molecules could perform similarly as the pT181 antisense
RNAs in sophisticated genetic networks, but with added
functionality to fine-tune their activity with small
molecules.
The strand exchange design can be used to create
protein-sensing ncRNAs
Equally important to sensing small molecules would be
the ability of ncRNAs to sense protein concentrations
and alter their regulatory functions accordingly. Here,
we used the MS2 coat protein-sensing aptamer for
several reasons. First, the natural MS2 coat protein
aptamer is well studied and binds to MS2 coat protein
with high affinity (Kd=20 pM) (30). Second, it has been
shown that the MS2 coat protein could be fused to
other proteins (31), serving as an adapter to sense other
intracellular proteins in vivo (32). Third, it has recently
been used to demonstrate a class of RNA control
devices that can couple the abundance of desired
proteins to targeted gene expression through alternative
RNA splicing (33).
Following the strand exchange design strategy, we
mutated the lower stem of the pT181 ncRNA hairpin to
base pair with the MS2 aptamer nucleotides that were
critical for MS2 coat protein binding (Figure 5A) (34).
We expected that without the MS2 coat protein, the
aptamer and ncRNA would fold together to disrupt the
ncRNA structure and inhibit its function; when the MS2
coat protein was present and bound to the aptamer, the
protein ligand would restore the pT181 ncRNA structure
and function. We designed five fusion mutants with dif-
ferent levels of base pairing between the ncRNA and the
aptamer, and tested them in E. coli with the pT181
reporter plasmid. We used an IPTG-inducible promoter
PLlacO-1 to induce the expression of MS2 coat protein
from the same ColE1 plasmids that harbored the fusion
variants (Supplementary Figure S1C). GFP expression
was measured with and without IPTG for each variant.
All designs were able to switch into an active state upon
induction of the MS2 coat protein (Supplementary Figure
S10), and one variant (#2) with the best performance,
called MS2–SE–pT181, was selected for further study
using flow cytometry (Figure 5B). The repression of
MS2–SE–pT181 fusion molecule almost covered the full
dynamic range of the wild-type ncRNA regulator. Once
again, the data suggested that strand exchange design was
acting like a switch, with the presence of MS2 coat protein
triggering a change in the conformation of the fusion
molecule to that allowed pT181 ncRNA to repress its
target. Further, using the fusion protein of the MS2 coat
protein and RFP, we observed a near-identical induction
curve, indicating that MS2 protein could indeed serve as
an adapter for sensing other intracellular proteins
(Supplementary Figure S11).
To confirm that the design of MS2–SE–pT181 was
modular with respect to pT181 mutants with different
target specificities, we constructed the MS2–SE–
pT181MT variant by directly swapping the target specifi-
city motif of the ncRNA, and tested the orthogonality
with and without MS2 coat protein expression
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(Supplementary Figure S12). Similar to the theo–SE–
pT181WT and theo–SE–pT181MT designs, the MS2–
SE–pT181WT and MS2–SE–pT181MT fusions acted or-
thogonally and only showed repression on their cognate
targets in the presence of MS2 coat proteins.
Orthogonal ncRNA sensors can integrate cellular signals
in logic circuits
To demonstrate the flexibility of using these engineered
ncRNA sensors to regulate gene expression, we used the
theo–SE–pT181WT and MS2–SE–pT181WT ncRNA
fusion molecules to regulate the same gene via the
wild-type pT181 sense attenuator. We expected that in
the presence of either theophylline or MS2 coat protein,
one of the aptamer–ncRNAs would be functional and
repress the expression of the target gene. In this way,
this system should be able to integrate two cellular
signals and act like a NOR logic. Indeed, In vivo fluores-
cence data indicated that GFP expression was high only
when there was no ligand present, and presence of either
theophylline or MS2 coat protein induced by IPTG or
both consistently repressed the reporter gene expression
to a low expression (Figure 5C). This demonstrated the
use of designed orthogonal aptamer–ncRNA fusions in
logically integrating cellular signals on the sensory-level.
Compared to the NOR logic using two orthogonal pT181
ncRNA-attenuator systems (4), here we showed that only
one pT181 ncRNA-attenuator pair was required for the
same regulatory function, implying sensory-level engineer-
ing using orthogonal ncRNA sensors could further
increase the scales and complexities of synthetic circuits.
DISCUSSION
Design principles for switchable aptamer–ncRNA fusions
In this work, we have demonstrated two alternative
designs to rationally engineer natural ncRNAs to sense
ligands by fusing them with RNA aptamers. The IS10
and pT181 ncRNAs are both highly structured and
likely to represent a class of ncRNA regulators whose
function highly depends on the structure (9). In our
designs, we fused RNA aptamer sequences to the 50 end
of the ncRNA molecules in the similar architecture as
natural riboswitches. We introduced mutations into differ-
ent locations in different designs to disrupt the ncRNA
structure: the mutations were on the aptamer loop
region to form pseudoknots with the ncRNA loop
(‘pseudoknot’ design); or the mutations were on the
ncRNA lower stem region to make this region exchange-
able between alternative conformations (‘strand exchange’
design). In both designs, ligand binding eliminated disrup-
tions on the ncRNA hairpin structures and activated their
functions (Supplementary Text S1).
In all designs, we have utilized the RNA structure pre-
diction algorithm, Mfold, to compute and verify that the
disrupted conformation had the lowest thermodynamic
free energy. Thus, without ligands, the structure of
ncRNA was disrupted. To explain the requirements for en-
gineered allosteric switching, we dissected the architecture
of the designed fusion molecule of the theo–SE–pT181
design, and calculated the hybridization free energy of
possible local RNA structures (Supplementary Text S2
and Supplementary Figure S9). Comparing three closely
related variants (MT-1, MT-2, MT-3) with the functional
design (WT), we discovered that allosteric switching was
not only determined by the interaction between the
ncRNA and the aptamer, but also by the ncRNA
folding itself. If there was over-disruption on ncRNA
(MT-1), the fusion molecule was always inactivated; if
the disruption was much weaker than the ncRNA
folding energy (MT-3), the ncRNA was always activated.
Only mutants with similar free energy between ncRNA
disruption and formation showed allosteric switching
(WT and MT-2). Surprisingly, one base-pair formation
or elimination in the ncRNA stem could completely
change the allosteric switching, indicating the allosteric
properties of designed aptamer–ncRNA fusions were sen-
sitive to nucleotide compositions.
Furthermore, we calculated free energy differences for
all 15 theophylline–SE–pT181 fusion mutants between al-
ternative conformations (Supplementary Figure S13). We
fitted the measured fluorescence data to the calculated free
energy differences, and observed almost linear correlation
between the two quantities for both with and without the
ligand. These experiments also suggest that the hybridiza-
tion free energy between adjacent RNA strands can serve
as a guide for designing allosteric properties of other
aptamer–ncRNA fusions.
Strengths and limitations of switchable aptamer–ncRNA
fusions
We have demonstrated a modular strategy for engineering
ligand-responsive ncRNAs. This builds from a growing
body of work on engineering gene circuits using RNA
mechanisms that respond to ligands. Previous work has
demonstrated that cis-acting RNA elements residing in the
50 (35,36) or 30- (37,38) UTR sequences can respond to
small molecules, and there was pioneering work to
engineer riboregulators in yeast to control translation in
response to small molecules (6). Our work here further
expands the category of RNA molecules that can
control gene expression in a ligand-inducible way to the
naturally occurring trans-acting ncRNAs that modulate
50-UTR functions. This is particularly valuable for tran-
scriptional ncRNA regulators, as transcriptional regula-
tors have been shown as useful genetic parts that could
be systematically tethered together to form logics and
other higher-order regulatory systems.
For the demonstration purpose, we fused theophylline-
or MS2 coat protein-sensing aptamers to ncRNAs. So
far, many RNA aptamers have been reported by in vitro
selection (39,40) or through the discovery of natural
riboswitches (10). These aptamers can bind specifically
to different ligands, including nucleotide-like molecules
such as flavin mononucleotide (FMN) (41) and
dopamine (42), complex compounds such as tetracycline
(43) and vitamin B12 (44), and proteins such as HIV-1 rev
peptide (45) or nicotine acetylcholine receptor (46). While
our design strategy worked well for theophylline and MS2
coat protein aptamers that possess relatively simple
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structures, to design functional fusions between complex
aptamers and ncRNAs, the detailed information about
their structures and mechanisms is needed. We foresee
the advent of high throughput RNA structure character-
ization methods such as SHAPE-Seq (47) will facilitate
our design process. Such methods will identify the
regions of aptamers that exhibit the appropriate flexibility
for intramolecular interaction with the ncRNA following
our design strategy. When connected to environmentally
or medically relevant ligands, we expect these ligand-
responsive RNA regulators offer novel capabilities to
engineer cellular behaviors in response to different stimuli.
By focusing on switchable trans-acting aptamer–
ncRNA fusions, we are extending this capability by
introducing modularity on both molecular and network
levels. First, at the molecular level, the modular design
of aptamer–ncRNA fusions allows the ligand sensed to
be switched with no further adjustment (Figure 6A).
Figures 3B and 5A show transcriptional regulation by
the same pT181 ncRNA molecule but modulated by two
different ligands—theophylline or MS2 coat protein. The
only difference between the two experiments is the particu-
lar aptamer–ncRNA fusion molecule expressed, and the
target of these aptamer–ncRNA fusions remains the same.
To achieve this with cis-acting elements, the genetic
context of the regulatory target would have to be
changed by manipulating the 50- or 30-UTRs since cis-
acting elements are inherently tightly coupled with their
regulatory target. However, unlike cis-acting elements, the
in trans nature of our regulatory elements allows the pos-
sibility of regulation of off-target genes. Nonetheless,
many ncRNAs are highly specific or can be engineered
to be so (4,12). An assumption of our study is that the
fusion of an aptamer to the ncRNA does not strongly
affect the properties of components. This is supported in
the present case by the maintenance of the quantitative
behavior of the fused ncRNA compared to the wild-type
ncRNA (Figure 3A and B). However, it is possible that
the fusion may interfere with the function and specificity
of both components—an eventuality that would need to
be diagnosed by structural and functional studies.
Although we only demonstrated the NOR logic by
having two different aptamer–ncRNA fusions to control
a single target, it is conceivable that other types of
sensory-level logic such as AND and OR can be theoret-
ically implemented by placing the complex logic into the
fusion molecules as suggested by other researchers (37).
For example, previous studies have demonstrated that
AND and OR functions could be engineered by fusing
two different aptamers to the same ribozyme (37), and
we expect a similar design could also work for the
aptamer–ncRNA fusions. We plan to investigate this
topic in our future study.
Second, at the gene network level, trans-acting
aptamer–ncRNA fusions have the potential to globally
change the regulation of many targets in response to cus-
tomizable cellular signals (Figure 6B). Many natural
ncRNAs have multiple targets in the cell (2), and by
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engineering the capability to fine-tune the post-
transcriptional function of these ncRNAs in response to
ligands, this work creates the opportunity to globally
switch on or off many targets in the cell simultaneously.
In addition to adding flexibility in an engineering context,
this could offer powerful capabilities to the scientific
toolkit to study ncRNA biology through dynamic
switching of global ncRNA regulators (48). Since we
have shown that our aptamer-pT181 designs are
modular with respect to both the aptamer and orthogonal
pT181 variants, there are numerous places that we can
integrate these fusion molecules into existing capabilities
to create more sophisticated RNA/protein or RNA-only
circuits with unique regulatory properties. Generally, tran-
scriptional aptamer–ncRNAs could be used as alternatives
to inducible promoters by having ncRNA responding
directly to the ligands after being expressed from consti-
tutive promoters; multiple signal integration at the sensor
level can compute logics on external stimuli whose outputs
could be fed into transcriptional logics for creation of
advanced logic gates (Figure 6C); and aptamer–ncRNA
fusion molecules themselves could serve as signal-
transmitting molecules in RNA/protein or RNA-only
networks to provide ligand-inducible control over
network connection (Figure 6D). The ability to sense
diverse signals (ncRNAs, proteins and metabolites) and
integrate them to execute gene regulatory programs
is key to the detection or implementation of specific
cellular responses in complex environments (49). The
modularity of aptamer–ncRNAs might offer powerful ex-
tensions to our capabilities for rationally engineering
trans-acting RNA regulators-mediated genetic circuits,
and the ubiquity of such mechanisms makes them poten-
tially useful across a diverse range of organisms, from
prokaryotes to humans (6). Coupled with the rapid
increase in our understanding of the regulatory roles of
trans-acting ncRNAs, this work opens the door for engin-
eering sensory-level gene regulations that are modular,
flexible and versatile based on naturally occurring trans-
acting ncRNAs.
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